01/22/2026
At IM Grand Rounds, we discussed how COPD management is moving beyond symptom-based treatment toward precision diagnosis and targeted therapy. Advanced imaging and new medications are reshaping what’s possible for patients. 
🔍 Key updates in COPD care:
✅ Greater use of CT imaging to better define lung physiology
✅ Identifying disease by lobe can open the door to surgical options
✅ Introduction of a new PDE-3/4 inhibitor inhaler
✅ Updates to the GOLD guidelines, expanding beyond triple therapy
✅ Dupilumab becomes the first biologic approved for COPD
These advances signal a shift toward more personalized and effective COPD treatment. Watch the full presentation: https://youtu.be/S9uElMqGCq0